GlassScriptPhysician profile
John C Boswell
NPI 1316991219
$2,008.89
in general payments reported to CMS, 2019-2025
14 companies · $419 in 2025
The $419 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.80 · 2020: $504 · 2021: $96.64 · 2022: $74.63 · 2023: $403 · 2024: $428 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,094.17 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $861.54 | 2020-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $536.24 | 2021-2025 | |
| Harmony Biosciences LLC | $273.09 | 2021-2025 | Wakix |
| Fisher & Paykel Healthcare INC | $91.11 | 2019-2025 | Fisher & Paykel Healthcare |
| Takeda Pharmaceuticals U.S.A., INC. | $47.39 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $36.83 | 2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $29.22 | 2019-2020 | |
| Glaxosmithkline, LLC. | $28.55 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $25.54 | 2025 | Lumryz |
| Lilly USA, LLC | $21.77 | 2025 | Zepbound |
| Itamar Medical INC | $15.79 | 2024 | Watchpatone |
| Circassia INC. | $15.37 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.58 | 2020 | |
| Allergan, INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.